| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | -0.08 | 0.02 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.02 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.03 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | 0.085 | 0.03 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.03 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.03 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.03 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.078 | 0.03 |
| mRNA | NU-7441 | GDSC1000 | pan-cancer | AAC | 0.078 | 0.03 |